{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:10:54Z","timestamp":1738703454538,"version":"3.37.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","geriatriconcology.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jgo.2024.102067","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T12:39:52Z","timestamp":1726490392000},"page":"102067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a prognostic nomogram in patients aged \u226565\u00a0years with stage I-II non-small cell lung cancer treated with stereotactic body radiotherapy"],"prefix":"10.1016","volume":"15","author":[{"given":"Xiaoqin","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanrong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jgo.2024.102067_bb0005","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non\u2013small cell lung cancer in the US","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.jgo.2024.102067_bb0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2213-2600(23)00050-4","article-title":"Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19\u00b7 67 million people and evaluation of model performance against seven other risk prediction models","volume":"11","author":"Liao","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.jgo.2024.102067_bb0015","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/JTO.0b013e3181d6e052","article-title":"Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment?","volume":"5","author":"Palma","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2024.102067_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.jgo.2024.102067_bb0025","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/1055-9965.EPI-15-0036","article-title":"Comorbidity and survival in lung cancer patients","volume":"24","author":"Islam","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.jgo.2024.102067_bb0030","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/ije\/dyaa057","article-title":"Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data","volume":"49","author":"Maringe","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.jgo.2024.102067_bb0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3322\/caac.21638","article-title":"Older adult participation in cancer clinical trials: a systematic review of barriers and interventions","volume":"71","author":"Sedrak","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.jgo.2024.102067_bb0040","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.07.1751","article-title":"Stereotactic body radiotherapy (SBRT) for operable stage I non\u2013small-cell lung cancer: can SBRT be comparable to surgery?","volume":"81","author":"Onishi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.jgo.2024.102067_bb0045","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/SLA.0000000000004363","article-title":"Stereotactic body radiotherapy versus delayed surgery for early-stage non-small-cell lung cancer","volume":"272","author":"Mayne","year":"2020","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.jgo.2024.102067_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.seminoncol.2018.06.002","article-title":"Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly","volume":"45","author":"Shinde","year":"2018","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2024.102067_bb0055","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ijrobp.2014.05.055","article-title":"Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis","volume":"90","author":"Zheng","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.jgo.2024.102067_bb0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.radonc.2013.06.045","article-title":"Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life","volume":"108","author":"Jain","year":"2013","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2024.102067_bb0065","article-title":"An analysis of clinical toxic effects and quality of life as a function of radiation dose and volume after lung stereotactic body radiation therapy","volume":"6","author":"Devpura","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"12","key":"10.1016\/j.jgo.2024.102067_bb0070","article-title":"Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study","volume":"3","author":"Feliciano","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2024.102067_bb0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijrobp.2019.09.037","article-title":"Predicting 5-year progression and survival outcomes for early stage non-small cell lung cancer treated with stereotactic ablative radiation therapy: development and validation of robust prognostic nomograms","volume":"106","author":"Kang","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jgo.2024.102067_bb0080","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1016\/j.annonc.2022.04.375","article-title":"P-286 prognostic factors for pancreatic adenocarcinoma: prognostic nutritional index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio","volume":"33","author":"Silva","year":"2022","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.jgo.2024.102067_bb0085","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-associated neutrophils in patients with cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2024.102067_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.jgo.2024.102067_bb0095","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.lungcan.2017.07.024","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab","volume":"111","author":"Diem","year":"2017","journal-title":"Lung Cancer"},{"issue":"23","key":"10.1016\/j.jgo.2024.102067_bb0100","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jgo.2024.102067_bb0105","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2024.102067_bb0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41389-022-00396-5","article-title":"Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2\/Smad\/ID1 pathway","volume":"11","author":"Lu","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jgo.2024.102067_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.595781","article-title":"Outcomes of stereotactic body radiotherapy for metastatic colorectal cancer with oligometastases, oligoprogression, or local control of dominant tumors","volume":"10","author":"Ji","year":"2021","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.jgo.2024.102067_bb0120","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM task group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"issue":"28","key":"10.1016\/j.jgo.2024.102067_bb0125","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1200\/JCO.19.00980","article-title":"Prediction of progression-free survival in patients with advanced, well-differentiated, neuroendocrine tumors being treated with a somatostatin analog: the GETNE-TRASGU study","volume":"37","author":"Carmona-Bayonas","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2024.102067_bb0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2019.08.032","article-title":"Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in child-Pugh B cirrhosis","volume":"72","author":"Berardi","year":"2020","journal-title":"J Hepatol"},{"issue":"18","key":"10.1016\/j.jgo.2024.102067_bb0135","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","article-title":"Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer","volume":"34","author":"Huang","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2024.102067_bb0140","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1470-2045(18)30080-9","article-title":"Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study","volume":"19","author":"Tang","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2024.102067_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.659987","article-title":"Clinical effects of stereotactic body radiation therapy targeting the primary tumor of liver-only oligometastatic pancreatic cancer","volume":"11","author":"Ji","year":"2021","journal-title":"Front Oncol"},{"issue":"10335","key":"10.1016\/j.jgo.2024.102067_bb0150","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jgo.2024.102067_bb0155","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1378\/chest.10-2841","article-title":"Surgical management and outcomes of elderly patients with early stage non-small cell lung cancer: a nested case-control study","volume":"140","author":"Rivera","year":"2011","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jgo.2024.102067_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.radonc.2011.04.005","article-title":"Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov model analysis","volume":"99","author":"Louie","year":"2011","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2024.102067_bb0165","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2024.102067_bb0170","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1007\/s00595-017-1536-4","article-title":"Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis","volume":"47","author":"Miyazaki","year":"2017","journal-title":"Surg Today"},{"issue":"1","key":"10.1016\/j.jgo.2024.102067_bb0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jtcvs.2016.03.060","article-title":"Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer","volume":"152","author":"Rosen","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jgo.2024.102067_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-019-1399-5","article-title":"Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (\u2265 70) patients with early-stage non-small cell lung cancer after propensity score matching","volume":"14","author":"Dong","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jgo.2024.102067_bb0185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1245\/s10434-014-3860-x","article-title":"Survival and treatment of non-small cell lung cancer stage I\u2013II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis","volume":"22","author":"Mokhles","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2024.102067_bb0190","first-page":"40","article-title":"Stereotactic body radiotherapy for medically inoperable stage I-II non\u2013small cell lung cancer: the Mayo Clinic experience","volume":"2","author":"Hobbs","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jgo.2024.102067_bb0195","article-title":"Results of stereotactic body radiation therapy (SBRT) for T2 lung cancer: Outcomes of longer term follow-up","volume":"35","author":"Shamp","year":"2017","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2024.102067_bb0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jtho.2019.08.2505","article-title":"Biologically effective dose in stereotactic body radiotherapy and survival for patients with early-stage NSCLC","volume":"15","author":"Moreno","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2024.102067_bb0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cllc.2021.06.008","article-title":"Nomogram predicting overall survival benefit of stereotactic ablative radiotherapy for early-stage non-small cell lung cancer","volume":"23","author":"Jacobs","year":"2022","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.jgo.2024.102067_bb0210","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jtcvs.2010.01.046","article-title":"Size matters: a comparison of T1 and T2 peripheral non\u2013small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)","volume":"140","author":"Dunlap","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.jgo.2024.102067_bb0215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijrobp.2015.05.003","article-title":"Predicting overall survival after stereotactic ablative radiation therapy in early-stage lung cancer: development and external validation of the Amsterdam prognostic model","volume":"93","author":"Louie","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.jgo.2024.102067_bb0220","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ijrobp.2018.01.050","article-title":"A retrospective long-term follow-up study of stereotactic body radiation therapy for non-small cell lung cancer from a single institution: incidence of late local recurrence","volume":"100","author":"Shintani","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.jgo.2024.102067_bb0225","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jgo.2024.102067_bb0230","article-title":"Platelet-to-lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy","volume":"40","author":"Fang","year":"2022","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.jgo.2024.102067_bb0235","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1245\/s10434-015-4518-z","article-title":"The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: which is better as a prognostic factor in gastric cancer?","volume":"22","author":"Kim","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jgo.2024.102067_bb0240","article-title":"Prognostic value of hematologic parameters in patients with muscle invasive bladder cancer","volume":"40","author":"Katiyar","year":"2022","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2024.102067_bb0245","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/JTO.0000000000000399","article-title":"Neutrophil\u2013lymphocyte and platelet\u2013lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non\u2013small-cell lung cancer","volume":"10","author":"Cannon","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2024.102067_bb0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cllc.2015.07.007","article-title":"Pretreatment immune parameters predict for overall survival and toxicity in early-stage non\u2013small-cell lung cancer patients treated with stereotactic body radiation therapy","volume":"17","author":"Shaverdian","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1016\/j.jgo.2024.102067_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-020-01537-z","article-title":"Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer","volume":"15","author":"Baker","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jgo.2024.102067_bb0260","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.radonc.2020.12.038","article-title":"The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma","volume":"156","author":"Duijm","year":"2021","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.jgo.2024.102067_bb0265","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1200\/JCO.2005.02.4695","article-title":"Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study","volume":"24","author":"Herder","year":"2006","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2024.102067_bb0270","doi-asserted-by":"crossref","first-page":"e93S","DOI":"10.1378\/chest.12-2351","article-title":"Evaluation of individuals with pulmonary nodules: when is it lung cancer?: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Gould","year":"2013","journal-title":"Chest"},{"issue":"9315","key":"10.1016\/j.jgo.2024.102067_bb0275","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(02)08352-6","article-title":"Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial","volume":"359","author":"Van Tinteren","year":"2002","journal-title":"Lancet"},{"issue":"35","key":"10.1016\/j.jgo.2024.102067_bb0280","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1200\/JCO.2010.30.0731","article-title":"Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non\u2013small-cell lung cancer: a population-based time-trend analysis","volume":"28","author":"Palma","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2024.102067_bb0285","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ijrobp.2016.12.022","article-title":"Stereotactic ablative radiation therapy is highly safe and effective for elderly patients with early-stage non-small cell lung cancer","volume":"98","author":"Brooks","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jgo.2024.102067_bb0290","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00432-020-03154-5","article-title":"Stereotactic body radiotherapy for elderly patients (\u2265 75 years) with early-stage non-small cell lung cancer","volume":"146","author":"Shu","year":"2020","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406824001735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406824001735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:54:28Z","timestamp":1738702468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406824001735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1879406824001735"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2024.102067","relation":{},"ISSN":["1879-4068"],"issn-type":[{"type":"print","value":"1879-4068"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a prognostic nomogram in patients aged \u226565\u00a0years with stage I-II non-small cell lung cancer treated with stereotactic body radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2024.102067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102067"}}